{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:59:35Z","timestamp":1775483975452,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12891-018-2077-8","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T13:16:17Z","timestamp":1526994977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac"],"prefix":"10.1186","volume":"19","author":[{"given":"Keiji","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomochika","family":"Kisukeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Zuinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"issue":"Suppl","key":"2077_CR1","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1097\/01.blo.0000143938.30681.9d","volume":"427","author":"JA Buckwalter","year":"2004","unstructured":"Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res. 2004;427(Suppl):S6\u201315.","journal-title":"Clin Orthop Relat Res"},{"key":"2077_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5694\/j.1326-5377.2006.tb00665.x","volume":"185","author":"D Schaffer","year":"2006","unstructured":"Schaffer D, Florin T, Eagle C, Marschner I, Singh G, Grobler M, et al. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust. 2006;185:501\u20136.","journal-title":"Med J Aust"},{"key":"2077_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00045391-200401000-00007","volume":"11","author":"RE Tarone","year":"2004","unstructured":"Tarone RE, Blot WJ, McLaughlin JK. Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: relative and absolute risk estimates from recent epidemiologic studies. Am J Ther. 2004;11:17\u201325.","journal-title":"Am J Ther"},{"key":"2077_CR4","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092\u2013102.","journal-title":"N Engl J Med"},{"key":"2077_CR5","first-page":"342","volume":"c7086","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;c7086:342.","journal-title":"BMJ"},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/CIA.S35416","volume":"7","author":"JH Peniston","year":"2012","unstructured":"Peniston JH, Gold MS, Wieman MS, Alwine LK. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012;7:517\u201323.","journal-title":"Clin Interv Aging"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00167-013-2408-0","volume":"22","author":"T Efe","year":"2014","unstructured":"Efe T, Sagnak E, Roessler PP, Getgood A, Patzer T, Fuchs-Winkelmann S, et al. Penetration of topical diclofenac sodium 4% spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial. Knee Surg Sports Traumatol Arthrosc. 2014;22:345\u201350.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2077_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1185\/03007995.2015.1113400","volume":"32","author":"LT Wadsworth","year":"2016","unstructured":"Wadsworth LT, Kent JD, Holt RJ. Efficacy and safety of diclofenac sodium 2%topical solution for osteoarthritis of the knee: a randomized, double-blind,vehicle-controlled, 4 week study. Curr Med Res Opin. 2016;32:241\u201350.","journal-title":"Curr Med Res Opin"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil. 2008;16:137\u201362.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18:476\u201399.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR11","doi-asserted-by":"crossref","unstructured":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on osteoarthritis guidelines. Arthritis Rheum. 2000;43:1905\u201315.","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P"},{"key":"2077_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.joca.2012.01.013","volume":"20","author":"V Strand","year":"2012","unstructured":"Strand V, Baraf HS, Lavin PT, Lim S, Hosokawa H. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2012;20:350\u20136.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR13","first-page":"775","volume":"31","author":"R Day","year":"2004","unstructured":"Day R, Brooks P, Conaghan PG, Petersen M. Multicenter trial group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775\u201382.","journal-title":"J Rheumatol"},{"key":"2077_CR14","first-page":"19","volume":"98","author":"AL Belle","year":"1950","unstructured":"Belle AL, Tislow R. A method of evaluating analgesics of the antiarthralgic type in the laboratory animal. J Pharm Exp Ther. 1950;98:19.","journal-title":"J Pharm Exp Ther"},{"key":"2077_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1254\/fpj.80.183","volume":"80","author":"H Nakamura","year":"1982","unstructured":"Nakamura H, Yokoyama Y, Motoyoshi S, Seto Y, Ishii K, Imazu C, et al. Anti-inflammatory and analgesic activities of a trans-cutaneous non-steroidal anti-inflammatory agent, etofenamate gel, in experimental animals.(in Japanese). Nippon Yakurigaku Zasshi. 1982;80:183\u201394.","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"2077_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1248\/yakushi1947.101.7_649","volume":"101","author":"H Nakamura","year":"1981","unstructured":"Nakamura H, Yokoyama Y, Ishii K, Motoyoshi S, Seto Y, Shimizu M. Effect of a non-steroidal anti-inflammatory drug, tolmetin sodium on arthritic pain, traumatic edema and LPS-induced fever. (in Japanese). Yakugaku Zasshi. 1981;101:649\u201356.","journal-title":"Yakugaku Zasshi"},{"issue":"11","key":"2077_CR17","first-page":"1555e69","volume":"33","author":"H Nakamura","year":"1983","unstructured":"Nakamura H, Yokoyama Y, Motoyoshi S, Ishii K, Imazu C, Seto Y, et al. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b, f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Arzneimittelforschung. 1983;33(11):1555e69.","journal-title":"Arzneimittelforschung"},{"key":"2077_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2010.08.012","volume":"647","author":"Y Tsukahara-Ohsumi","year":"2010","unstructured":"Tsukahara-Ohsumi Y, Tsuji F, Niwa M, Nakamura M, Mizutani K, Inagaki N, et al. SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects. Eur J Pharmacol. 2010;647:62\u20137.","journal-title":"Eur J Pharmacol"},{"key":"2077_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1254\/fpj.69.319","volume":"69","author":"K Tsurumi","year":"1973","unstructured":"Tsurumi K, Hiramatsu Y, Yamaguchi A, Hayashi M, Shibuya T, Fujimura H. Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation. (in Japanese). Nippon Yakurigaku Zasshi. 1973;69:319\u201334.","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"2077_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1254\/fpj.87.89","volume":"87","author":"M Kiniwa","year":"1986","unstructured":"Kiniwa M, Yamamoto N, Hashimoto Y, Miyake H, Masuda H. Anti-inflammatory effect of THS-201, a new intra-articular steroid. (in Japanese). Nippon Yakurigaku Zasshi. 1986;87:89\u201397.","journal-title":"Nippon Yakurigaku Zasshi."},{"key":"2077_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/ard.48.8.623","volume":"48","author":"ER Pettipher","year":"1989","unstructured":"Pettipher ER, Henderson B, Edwards JC, Higgs GA. Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis. 1989;48:623\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2077_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.2042-7158.1993.tb05692.x","volume":"45","author":"KL Green","year":"1993","unstructured":"Green KL, Foong WC. Treatment of antigen-induced arthritis in rabbits by the intra-articular injection of methylprednisolone, 90Y or chlorambucil. J Pharm Pharmacol. 1993;45:815\u201320.","journal-title":"J Pharm Pharmacol"},{"key":"2077_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ard.32.2.103","volume":"32","author":"KN Antonas","year":"1973","unstructured":"Antonas KN, Fraser JR, Muirden KD. Distribution of biologically labelled radioactive hyaluronic acid injected into joints. Ann Rheum Dis. 1973;32:103\u201311.","journal-title":"Ann Rheum Dis"},{"key":"2077_CR24","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.joca.2006.05.015","volume":"14","author":"DW Jackson","year":"2006","unstructured":"Jackson DW, Simon TM. Intra-articular distribution and residence time of Hylan a and B: a study in the goat knee. Osteoarthr Cartil. 2006;14:1248\u201357.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/0092-8674(90)90694-A","volume":"61","author":"A Aruffo","year":"1990","unstructured":"Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303\u201313.","journal-title":"Cell"},{"key":"2077_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF01541320","volume":"15","author":"LP Hale","year":"1995","unstructured":"Hale LP, Haynes BF, McCachren SS. Expression of CD44 variants in human inflammatory synovitis. J Clin Immunol. 1995;15:300\u201311.","journal-title":"J Clin Immunol"},{"key":"2077_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2125.2008.03333.x","volume":"67","author":"S Miyatake","year":"2009","unstructured":"Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol. 2009;67:125\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"2077_CR28","first-page":"255","volume":"15","author":"T Mashima","year":"1995","unstructured":"Mashima T, Kondo M, Sakiyama N. Concentrations of Voltaren (diclofenac sodium) SR capsule in serum and tissues of patients with rheumatoid arthritis. Japanese journal of inflammation (Japan). 1995;15:255\u20139.","journal-title":"Japanese journal of inflammation (Japan)"},{"key":"2077_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/s10165-008-0067-7","volume":"18","author":"SM Julovi","year":"2008","unstructured":"Julovi SM, Ito H, Hiramitsu T, Yasuda T, Nakamura T. Hyaluronan inhibits IL-1\u03b2-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells. Mod Rheumatol. 2008;18:263\u201370.","journal-title":"Mod Rheumatol"},{"key":"2077_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jor.20558","volume":"26","author":"Y Mitsui","year":"2008","unstructured":"Mitsui Y, Gotoh M, Nakamura K, Yamada T, Higuchi F, Nagata K. Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2\/prostaglandin E(2) production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res. 2008;26:1032\u20137.","journal-title":"J Orthop Res"},{"key":"2077_CR31","first-page":"377","volume":"19","author":"M Goto","year":"2001","unstructured":"Goto M, Hanyu T, Yoshio T, Matsuno H, Shimizu M, Murata N, et al. Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol. 2001;19:377\u201383.","journal-title":"Clin Exp Rheumatol"},{"key":"2077_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1254\/fpj.92.17","volume":"92","author":"S Gotoh","year":"1988","unstructured":"Gotoh S, Miyazaki K, Onaya J, Sakamoto T, Tokuyasu K, Namiki O. Experimental knee pain model in rats and analgesic effect of sodium hyaluronate (SPH). (in Japanese). Nippon Yakurigaku Zasshi. 1988;92:17\u201327.","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"2077_CR33","unstructured":"Prescribing Information for Voltaren 1% Gel (diclofenac sodium topical gel). (revised: Nov. 2011, NDA No. 022 122)."},{"key":"2077_CR34","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/art.21357","volume":"52","author":"M Reijman","year":"2005","unstructured":"Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam study. Arthritis Rheum. 2005;52:3137\u201342.","journal-title":"Arthritis Rheum"},{"key":"2077_CR35","first-page":"1941","volume":"22","author":"EC Huskisson","year":"1995","unstructured":"Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK study group. Longitudinal investigation of nonsteroidal Antiinflammatory drugs in knee osteoarthritis. J Rheumatol. 1995;22:1941\u20136.","journal-title":"J Rheumatol"},{"key":"2077_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1015504632021","volume":"26","author":"C Ding","year":"2002","unstructured":"Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation. 2002;26:139\u201342.","journal-title":"Inflammation"},{"key":"2077_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s003930050161","volume":"58","author":"JT Dingle","year":"1999","unstructured":"Dingle JT. The effects of NSAID on the matrix of human articular cartilages. Z Rheumatol. 1999;58:125\u20139.","journal-title":"Z Rheumatol"},{"key":"2077_CR38","first-page":"1130","volume":"22","author":"RL Smith","year":"1995","unstructured":"Smith RL, Kajiyama G, Lane NE. Nonsteroidal antiinflammatory drugs: effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. J Rheumatol. 1995;22:1130\u20137.","journal-title":"J Rheumatol"},{"key":"2077_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/rheumatology\/32.7.595","volume":"32","author":"P Dieppe","year":"1993","unstructured":"Dieppe P, Cushnaghan J, Jasani MK, McCrae F, Watt I. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol. 1993;32:595\u2013600.","journal-title":"Br J Rheumatol"},{"key":"2077_CR40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.joca.2008.09.002","volume":"17","author":"TN de Boer","year":"2009","unstructured":"de Boer TN, Huisman AM, Polak AA, Niehoff AG, van Rinsum AC, Saris D, et al. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthr Cartil. 2009;17:482\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.joca.2006.11.001","volume":"15","author":"M Mihara","year":"2007","unstructured":"Mihara M, Higo S, Uchiyama Y, Tanabe K, Saito K. Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model. Osteoarthr Cartil. 2007;15:543\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR42","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.joca.2009.04.018","volume":"17","author":"M Hashizume","year":"2009","unstructured":"Hashizume M, Mihara M. Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production. Osteoarthr Cartil. 2009;17:1513\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"2077_CR43","first-page":"1593","volume":"19","author":"A Okada","year":"2009","unstructured":"Okada A, Okada Y. Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis. Clin Calcium. 2009;19:1593\u2013601.","journal-title":"Clin Calcium"},{"key":"2077_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4:157\u201364.","journal-title":"Arthritis Res"},{"key":"2077_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138920108783497659","volume":"9","author":"H Takaishi","year":"2008","unstructured":"Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol. 2008;9:47\u201354.","journal-title":"Curr Pharm Biotechnol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-018-2077-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T05:48:47Z","timestamp":1571377727000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-018-2077-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/s12891-018-2077-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal studies were reviewed and approved by the Animal Experiment Ethics Committee of Seikagaku Corporation and performed under the animal husbandry\/management system in an appropriate environment with animal protection\/welfare in mind.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors of this paper are employees of Seikagaku Corporation. The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}